FOS and Hepatitis: In concurrence with our LPS/D-GalN-treated mice hepatitis experimental model, the upregulation of phosphorylated MKK4 and c-Fos in the liver tissue was markedly suppressed by orally administered Pc-ME (Figure 5(d)).